# Pharmacokinetics, Safety, and Lung Deposition of 99mTc-DTPA Delivered Via the EDDIS System in Healthy Volunteers

> **NCT07053696** · PHASE1 · WITHDRAWN · sponsor: **Andrey Petrov**

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Technetium-99m Diethylenetriaminepentaacetic Acid
- **DEVICE:** EDDIS-IDDS (Enhanced Digital Dose Inhalation Delivery System)

## Key facts

- **NCT ID:** NCT07053696
- **Lead sponsor:** Andrey Petrov
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2025-03-17
- **Primary completion:** 2025-11-17
- **Final completion:** 2025-11-17
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Changing regulatory requirements requiring changes in study design. Participants were not enrolled
- **Last updated:** 2025-11-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07053696

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07053696, "Pharmacokinetics, Safety, and Lung Deposition of 99mTc-DTPA Delivered Via the EDDIS System in Healthy Volunteers". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT07053696. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*